WallStreetZenWallStreetZen

NASDAQ: BVS
Bioventus Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BVS past revenue growth

How has BVS's revenue growth performed historically?
Company
29.47%
Industry
10.63%
Market
21.77%
BVS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BVS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BVS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BVS earnings and revenue history

Current Revenue
$516.7M
Current Earnings
-$127.1M
Current Profit Margin
-24.6%

BVS Return on Equity

Current Company
-29.9%
Current Industry
78%
Current Market
-8.3%
BVS's Return on Equity (-29.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BVS announces earnings.

BVS Return on Assets

Current Company
-10.1%
Current Industry
6.3%
BVS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BVS Return on Capital Employed

Current Company
-14.75%
Current Industry
10.8%

BVS vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BVS$516.70M-$108.32M-$127.14M+27.05%N/A
DRIO$27.66M-$57.47M-$63.84M+39.85%N/A
DMTK$14.52M-$112.22M-$116.68M+56.15%N/A
MYNZ$399.84k-$23.76M-$24.03M-46.27%N/A
PRE$275.76MN/A-$190.45M+133.77%N/A
View Top Diagnostic & Research Stocks

BVS earnings dates

Next earnings date
Mar 30, 2023

Bioventus Earnings & Revenue FAQ

What were BVS's earnings last quarter?

On Invalid Date, Bioventus (NASDAQ: BVS) reported Q3 2022 earnings per share (EPS) of -$1.76, up 5,766.67% year over year. Total Bioventus earnings for the quarter were -$108.25 million. In the same quarter last year, Bioventus's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Bioventus stock.

What was BVS's earnings growth in the past year?

As of Q1 2023, Bioventus's earnings has grown year over year. Bioventus's earnings in the past year totalled -$127.14 million.

What is BVS's earnings date?

Bioventus's earnings date is Invalid Date. Add BVS to your watchlist to be reminded of BVS's next earnings announcement.

What was BVS's revenue last quarter?

On Invalid Date, Bioventus (NASDAQ: BVS) reported Q3 2022 revenue of $128.66 million up 18.16% year over year. In the same quarter last year, Bioventus's revenue was $108.89 million.

What was BVS's revenue growth in the past year?

As of Q1 2023, Bioventus's revenue has grown 29.47% year over year. This is 18.85 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 10.63%. Bioventus's revenue in the past year totalled $516.70 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.